Literature DB >> 22349533

[Cardiopulmonary emergencies during pregnancy and the postpartum period].

M Rosenberg1, N Frey.   

Abstract

The number of patients who develop cardiac problems during pregnancy are increasing and represent to date the major cause of maternal death in western countries. Pregnancy induces several changes which together increase the hemodynamic burden on the cardiovascular system and can also cause a prothrombotic state. Hence, latent or apparent cardiac disease can acutely decompensate during pregnancy. From a cardiovascular perspective, pregnancies are most often complicated by acute coronary syndromes, peripartum cardiomyopathy, arrhythmias, or pulmonary embolism. Due to potential fetal harm conventional diagnostic and therapeutic approaches are limited by the restricted use of radiogenic cardiac imaging and applicable medications. Therefore, knowledge about available therapeutic options is of greatest importance, since guideline recommendations have clearly been demonstrated to reduce morbidity and mortality in acute cardiac emergencies during pregnancy.

Entities:  

Mesh:

Year:  2012        PMID: 22349533     DOI: 10.1007/s00063-011-0039-0

Source DB:  PubMed          Journal:  Med Klin Intensivmed Notfmed        ISSN: 2193-6218            Impact factor:   0.840


  39 in total

1.  Maternal cardiac troponin I levels during normal labor and delivery.

Authors:  S A Shivvers; F H Wians; J H Keffer; S M Ramin
Journal:  Am J Obstet Gynecol       Date:  1999-01       Impact factor: 8.661

Review 2.  Treatment of cardiac arrhythmias during pregnancy: safety considerations.

Authors:  J A Joglar; R L Page
Journal:  Drug Saf       Date:  1999-01       Impact factor: 5.606

3.  Electrocardiographic changes during cesarean section.

Authors:  B Kleinman
Journal:  Anesthesiology       Date:  1993-05       Impact factor: 7.892

4.  D-dimer concentrations in normal pregnancy: new diagnostic thresholds are needed.

Authors:  Jeffrey A Kline; Ginger W Williams; Jackeline Hernandez-Nino
Journal:  Clin Chem       Date:  2005-03-11       Impact factor: 8.327

Review 5.  Cardiac arrhythmias in pregnancy: clinical and therapeutic considerations.

Authors:  Ramesh M Gowda; Ijaz A Khan; Nirav J Mehta; Balendu C Vasavada; Terrence J Sacchi
Journal:  Int J Cardiol       Date:  2003-04       Impact factor: 4.164

6.  Myocardial ischaemia in normal patients undergoing elective Caesarean section: a peripartum assessment.

Authors:  C Moran; M Ni Bhuinneain; M Geary; S Cunningham; P McKenna; J Gardiner
Journal:  Anaesthesia       Date:  2001-11       Impact factor: 6.955

7.  A cathepsin D-cleaved 16 kDa form of prolactin mediates postpartum cardiomyopathy.

Authors:  Denise Hilfiker-Kleiner; Karol Kaminski; Edith Podewski; Tomasz Bonda; Arnd Schaefer; Karen Sliwa; Olaf Forster; Anja Quint; Ulf Landmesser; Carola Doerries; Maren Luchtefeld; Valeria Poli; Michael D Schneider; Jean-Luc Balligand; Fanny Desjardins; Aftab Ansari; Ingrid Struman; Ngoc Q N Nguyen; Nils H Zschemisch; Gunnar Klein; Gerd Heusch; Rainer Schulz; Andres Hilfiker; Helmut Drexler
Journal:  Cell       Date:  2007-02-09       Impact factor: 41.582

8.  Long-term outcomes of cardiac transplantation for peri-partum cardiomyopathy: a multiinstitutional analysis.

Authors:  Kismet D Rasmusson; Josef Stehlik; Robert N Brown; Dale G Renlund; Lynne E Wagoner; Guillermo Torre-Amione; Jan W Folsom; David H Silber; James K Kirklin
Journal:  J Heart Lung Transplant       Date:  2007-11       Impact factor: 10.247

Review 9.  Antiphospholipid syndrome.

Authors:  Diane George; Doruk Erkan
Journal:  Prog Cardiovasc Dis       Date:  2009 Sep-Oct       Impact factor: 8.194

10.  Guidelines on the diagnosis and management of acute pulmonary embolism: the Task Force for the Diagnosis and Management of Acute Pulmonary Embolism of the European Society of Cardiology (ESC).

Authors:  Adam Torbicki; Arnaud Perrier; Stavros Konstantinides; Giancarlo Agnelli; Nazzareno Galiè; Piotr Pruszczyk; Frank Bengel; Adrian J B Brady; Daniel Ferreira; Uwe Janssens; Walter Klepetko; Eckhard Mayer; Martine Remy-Jardin; Jean-Pierre Bassand
Journal:  Eur Heart J       Date:  2008-08-30       Impact factor: 29.983

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.